Risk of withdrawal of consent for treatment with long-acting injectable versus oral antipsychotics: A meta-analysis of randomized controlled trials

Despite the clinical importance of antipsychotic long-acting injections (LAIs) in the treatment of schizophrenia, their use may be limited by patients' reluctance to accept the injections. No studies to date have investigated whether patients are more likely to withdraw their consent to treatme...

Full description

Bibliographic Details

Published in:	Schizophrenia research Vol. 229; pp. 94 - 101
Main Authors:	Yaegashi, Hodaka, Misawa, Fuminari, Noda, Hokuto, Fujii, Yasuo, Takeuchi, Hiroyoshi
Format:	Journal Article
Language:	English
Published:	Netherlands Elsevier B.V 01-03-2021
Subjects:	Antipsychotics Discontinuation Long-acting injection Schizophrenia Withdrawal of consent Schizophrenia Antipsychotics Withdrawal of consent Discontinuation Long-acting injection
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!